Inventor · disambiguated record
Christopher Harvey
Also filed as: HARVEY CHRISTOPHER · HARVEY CHRISTOPHER ANTHONY QUE
8 granted patents·13 pending applications·39 citations·filing 2006–2023
83Inventor score
Files withJOUNCE THERAPEUTICS INC10DANA FARBER CANCER INST INC4PHENOMIC AI4AIR PROD & CHEM1DANA-FARBER CANCER INST1
Top patents by PatentIndex Score
21 records- 0188US9402905B2Therapeutic peptidesDANA FARBER CANCER INST INC·Filed 2013·Granted Aug 2, 2016·14 cites·24 claims
- 0280US11292840B2Methods of treating cancer in a subject having elevated ICOS and/or T-bet levels of CD+4 cells by administering an ICOS agonistJOUNCE THERAPEUTICS INC·Filed 2019·Granted Apr 5, 2022·3 cites·19 claims
- 0380US10968277B2Gene signatures for determining ICOS expressionJOUNCE THERAPEUTICS INC·Filed 2016·Granted Apr 6, 2021·2 cites·21 claims
- 0480US10793633B2Therapeutic peptidesDANA FARBER CANCER INST INC·Filed 2016·Granted Oct 6, 2020·2 cites·3 claims
- 0580US10106611B2Antibodies that bind to MHC class I polypeptide-related sequence ADANA FARBER CANCER INST INC·Filed 2014·Granted Oct 23, 2018·5 cites·36 claims
- 0674US7468132B2Method for treatment of animal wasteAIR PROD & CHEM·Filed 2006·Granted Dec 23, 2008·12 cites·11 claims
- 0766US10279021B2Vaccine compositions and methods for restoring NKG2D pathway function against cancersDANA FARBER CANCER INST INC·Filed 2015·Granted May 7, 2019·1 cites·25 claims
- 0863US2025215070A1Anti-cthrc1 fusion proteins and methods of using the samePHENOMIC AI·Filed 2023·Application pending·0 cites
- 0962US2022332823A1Methods of treating cancerJOUNCE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1062US2025213710A1Anti-collagen triple helix repeat containing 1 (cthrc1) antibodies and methods of using the samePHENOMIC AI·Filed 2023·Application pending·0 cites
- 1160US2022281978A1Compositions and Methods for the Treatment of Cancer (Anti-ICOS Antibody Dosing)JOUNCE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1257US2021340256A1Gene Signatures for Determining ICOS ExpressionJOUNCE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1352US10745483B2Therapeutic peptidesDANA-FARBER CANCER INSTITUTE INC·Filed 2014·Granted Aug 18, 2020·0 cites·6 claims
- 1452US2023151098A1Compositions and Methods for Vaccination and the Treatment of Infectious DiseasesJOUNCE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1549US2022135682A1Anti-ICOS Antibodies for the Treatment of CancerJOUNCE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1647US2025059267A1Combination therapy for treatment of tumors comprising cancer-associated fibroblastsPHENOMIC AI·Filed 2022·Application pending·0 cites
- 1745US2020024351A1Compositions and Methods for the Treatment of CancerJOUNCE THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1844US2021355222A1Methods of Treating CancerJOUNCE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1943US2025270304A1Anti-activin antibodies and methods of using the samePHENOMIC AI·Filed 2021·Application pending·0 cites
- 2042US2021380942A1Methods and compositions for the treatment of cancer and infectious diseasesJOUNCE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2139US2017198054A1Methods for treating cancer with anti bip or anti mica antibodiesDANA-FARBER CANCER INST·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christopher Harvey files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →